chestnutpost

[chestnutpost]

President Trump FULL REMARKS on 75th Anniversary of D-Day (C-SPAN)

The post President Trump FULL REMARKS on 75th Anniversary of D-Day (C-SPAN) appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/president-trump-full-remarks-on-75th-anniversary-of-d-day-c-span/

[chestnutpost]

CMT Awards 2019: Best Moments of Country’s Big Night — Watch!

The post CMT Awards 2019: Best Moments of Country’s Big Night — Watch! appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/cmt-awards-2019-best-moments-of-countrys-big-night-watch/

[chestnutpost]

Steph Curry scoring 47 without KD and Klay ‘sounds about right’ – Richard Jefferson | Get Up

The post Steph Curry scoring 47 without KD and Klay ‘sounds about right’ – Richard Jefferson | Get Up appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/steph-curry-scoring-47-without-kd-and-klay-sounds-about-right-richard-jefferson-get-up/

[chestnutpost]

Trump and Macron hold bilateral meeting

The post Trump and Macron hold bilateral meeting appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/trump-and-macron-hold-bilateral-meeting/

[chestnutpost]

Odell Beckham Jr. Partners With Shock Doctor to Launch New Interchange Lip Guard

“I’m excited to partner with a company that takes performance as seriously as I do,” Beckham said. “Shock Doctor does mouthguards better than anybody, and now they have the best lip guard in the game with Interchange. Big things coming soon — including my own designs.”

With a standard lip guard, the user’s only option is one fixed shield attached permanently to the mouthpiece. With the new Shock Doctor Interchange lip guard, athletes have the ability to quickly and easily change out their shields, providing a variety of different looks. Solid, print and chrome Shield designs feature the latest trends for the most current on-field looks.

This patent-pending technology brings a level of personalization and style never seen before in a lip guard product. After buying the Interchange mouthpiece and shield together, a user can then buy different Interchange Shield designs (available in single and double packs) and change them out on the same mouthpiece in just a few seconds. It’s comfortable, ready to use out of the box — no boiling required — and has a $50,000 dental warranty, which is the highest in the industry among lip guards.

“Shock Doctor Interchange is the most exciting innovation the lip guard category has ever seen,” said Michael Magerman, President and CEO of United Sports Brands, the parent company of Shock Doctor. “It only makes sense to have the world’s most exciting NFL player partner with us to help bring it to football players at every level.”

WME represents Beckham and negotiated the partnership on his behalf with Shock Doctor.

The Shock Doctor Interchange Mouthpiece and Shield, along with Shields Only, are available at Dick’s Sporting Goods and other leading national sporting goods retailers. Follow Shock Doctor on Instagram for all Interchange content, Shield drops and collaborations with #ChangeYourShield #MakeYourMark. Learn more at ShockDoctor.com/Interchange.

The Shock Doctor Interchange Mouthpiece and Shield start at $16.99. Shields Only start at $9.99.

About Shock DoctorShock Doctor, the undisputed leader in mouthguard technology and the #1 mouthguard in the world, is a leader in sports protection and performance around the globe. At the forefront of innovation for more than 25 years, Shock Doctor provides performance-driven and protective equipment for athletes across a range of sports, including football, basketball, hockey, baseball, lacrosse, field hockey, MMA, fitness and more. For more information, visit www.ShockDoctor.com.

SOURCE Shock Doctor

Related Links

http://www.shockdoctor.com

The post Odell Beckham Jr. Partners With Shock Doctor to Launch New Interchange Lip Guard appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/odell-beckham-jr-partners-with-shock-doctor-to-launch-new-interchange-lip-guard/

[chestnutpost]

La FDA octroie une approbation préalable à la commercialisation au système de remplacement complet de la cheville Hintermann série H3™ de DT MedTech

Le H3 a été mis au point par le professeur Beat Hintermann, un chirurgien du pied et de la cheville de renommée mondiale basé à Liestal, en Suisse. Le H3 a été implanté chez plus de 20 000 patients en dehors des États-Unis depuis sa première sortie en mai 2000.

Le professeur Hintermann a déclaré : « Je suis très fier de cette réussite. Depuis la pose du premier H3, j’ai toujours rêvé de pouvoir proposer le H3 sur le marché américain afin d’y améliorer les soins apportés aux patients et les résultats thérapeutiques. Nous avons obtenu des résultats spectaculaires avec le H3 en dehors des États-Unis et nous sommes impatients de pouvoir proposer ce système de remplacement complet de la cheville aux chirurgiens américains. »

Selon le résumé des données de sécurité et d’efficacité de la FDA, les données cliniques utilisées pour soutenir l’approbation préalable à la commercialisation ont montré que 95,9 % des patients ayant reçu un H3 étaient modérément satisfaits ou très satisfaits de la procédure cinq ans après la pose de la prothèse et que le taux de survie à sept ans s’élevait à 88 %.

David Reicher, PDG de DTM, a déclaré : « Nous sommes extrêmement heureux d’avoir reçu cette approbation pour le H3. Je souhaite remercier le Dr Beat Hintermann et son équipe, tous les employés de M Squared Associates, nos conseillers et nos principaux partenaires, ainsi que tous nos employés de Data Trace pour la persévérance et le travail acharné dont ils ont fait preuve pour parvenir à cet objectif majeur. »

Outre le système TAR à roulement mobile H3, DTM continuera à commercialiser la prothèse Hintermann série H2® (H2), un système TAR semi-contraint cimenté en deux pièces qui a reçu l’autorisation de commercialisation 510(k) en novembre 2017. Les chirurgiens auront désormais la possibilité, à l’aide d’un seul ensemble d’instruments, d’offrir à leurs patients une solution complète en utilisant le H3 ou le H2 pour réaliser un remplacement complet de la cheville primaire.

Pour des informations supplémentaires sur DTM aux États-Unis, veuillez écrire à [email protected] ou appeler le 410-427-0003 ; en dehors des États-Unis, veuillez écrire à [email protected] ou appeler le [phone].

À propos de DT MedTech, LLC

DT MedTech, LLC est la société mère de DT MedTech International Limited et d’European Foot Platform, S.A.R.L. DTM et ses filiales ont des bureaux à Baltimore (Maryland, États-Unis), Dublin (Irlande), Saint-Louis (France) et Liestal (Suisse). Depuis plus de 30 ans, la famille de sociétés Data Trace fait figure de chef de file de l’édition scientifique et médicale, du marketing, de la formation en chirurgie, de la gestion d’essais cliniques, de l’assurance contre les erreurs médicales et des services d’information.

Photo – https://mma.prnewswire.com/media/898388/DT_MedTech_LLC_H3_Composite_DoubleCoat_Left_Facing.jpg

Related Links

http://www.dtmedtech.com

SOURCE DT MedTech, LLC

The post La FDA octroie une approbation préalable à la commercialisation au système de remplacement complet de la cheville Hintermann série H3™ de DT MedTech appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/la-fda-octroie-une-approbation-prealable-a-la-commercialisation-au-systeme-de-remplacement-complet-de-la-cheville-hintermann-serie-h3-de-dt-medtech/

[chestnutpost]

7-month-old Caroline Collett only answers to the name ‘Alexa’ | GMA Digital

The post 7-month-old Caroline Collett only answers to the name ‘Alexa’ | GMA Digital appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/7-month-old-caroline-collett-only-answers-to-the-name-alexa-gma-digital/

[chestnutpost]

Thinking about buying stock in AMD, Canopy Growth, Ciena, Contravir, or Uber?

NEW YORK, June 6, 2019 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for AMD, CGC, CIEN, CTRV, and UBER.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver’s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock’s overall suitability for investment.

SOURCE InvestorsObserver

Related Links

http://www.investorsobserver.com

The post Thinking about buying stock in AMD, Canopy Growth, Ciena, Contravir, or Uber? appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/thinking-about-buying-stock-in-amd-canopy-growth-ciena-contravir-or-uber/

[chestnutpost]

InvestorsObserver releases stock and option data on Beyond Meat, Salesforce, Dell, Lyft, and Target

NEW YORK, June 6, 2019 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for BYND, CRM, DELL, LYFT, and TGT.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

SOURCE InvestorsObserver

Related Links

http://www.investorsobserver.com

The post InvestorsObserver releases stock and option data on Beyond Meat, Salesforce, Dell, Lyft, and Target appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/investorsobserver-releases-stock-and-option-data-on-beyond-meat-salesforce-dell-lyft-and-target/

[chestnutpost]

IBC Updates and Corrects the Record on Utah Litigation against Ucore Rare Metals, Inc.

AMERICAN FORK, Utah, June 6, 2019 /PRNewswire/ — IBC Advanced Technologies, Inc. (“IBC”) is pleased to update on the legal process surrounding the complaints filed by IBC against Ucore Rare Metals, Inc. (“Ucore”) and other defendants (collectively, the “Defendants”) in Utah, with jury trials demanded:

On February 19, 2019, IBC commenced a lawsuit against Ucore, Jim McKenzie and Peter Manuel, which is currently pending in the Federal District Court for the State of Utah (the “Federal Action”). The case advances contractual, common law and statutory claims, including breach of contract, breach of implied covenant of good faith and fair dealing, negligent misrepresentation, fraudulent concealment or fraudulent nondisclosure, breach of fiduciary duty, promissory estoppel, unjust enrichment and fraudulent inducement.  IBC has demanded relief in excess of USD $40 million in the Federal Action.

In addition, IBC has commenced an action the state court of Utah (the “State Action”). That action was filed on January 2, 2019 against Ucore, Jim McKenzie, Mark MacDonald, Randy McGillivray, and John Does I and II, The State Action alleges Ucore has violated common and statutory law, by among other things, misappropriation of IBC’s trade secrets and confidential information, infringement of IBC’s trademarks, unfair competition, misrepresentation of IBC’s intellectual property as Ucore’s own; defamation of IBC and Steven Izatt, painting IBC and Steven Izatt in a false light, tortious interference with IBC’s economic relations, and unjust enrichment.  IBC is seeking not less than USD $20 million in damages in the State Action.

No judgment has yet been entered in either the Federal Action or the State Action.

Summary

In connection with the State Action, IBC filed, on May 9, 2019, a motion and memorandum of law in support of a temporary restraining order and preliminary injunction against Ucore (the “TRO”). On May 24, 2019, the Court heard arguments in the State Action regarding whether the Court had jurisdiction over the Defendants, who consist of a Canadian company and Canadian citizens. The Court found that the allegations in IBC’s complaint were insufficient to establish jurisdiction, but permitted IBC to file an amended complaint to make further allegations against Ucore and the other Defendants in order to demonstrate personal jurisdiction. IBC intends to file a motion to amend the complaint as permitted by the Court this week, which will allow the Court to reconsider its decision based upon the amended complaint’s further allegations against Ucore and the other Defendants.

Significantly, because the Court determined that it did not currently have the power to exercise jurisdiction over the Defendants, it did not hear evidence regarding the TRO and did not rule on the issues presented in the TRO. The TRO raises very significant questions regarding previously undisclosed information concerning, among other things, the feasibility of Ucore’s plans to develop the Bokan Mine.

For those persons or entities that are IBC’s current or potential clients, and/or vendors, and/or others with significant interest in IBC and/or the industry, IBC’s TRO and Ucore’s opposition to that motion can be found by clicking on the link below and making the required certifications: http://bit.ly/ibcmrt

“IBC thanks all of its stakeholders, including shareholders, customers, and employees, for their strong support,” stated Mr. Steven R. Izatt, President and CEO of IBC. “IBC’s proud history of technology development and delivery of exceptional products will continue unabated.”

Background

IBC is an award-winning provider of proprietary and innovative Molecular Recognition Technology (“MRT”) products and processes, based on green chemistry and green engineering, to premier customers worldwide. IBC’s SuperLig®, AnaLig® and MacroLig® products and associated processes are used in manufacturing, analytical and laboratory applications.

IBC was founded in 1988 by, and named after, three Brigham Young University professors: Dr. Reed M. Izatt, Dr. Jerald S. Bradshaw and Dr. James J. Christensen.

IBC is the proud sponsor of the International Izatt-Christensen Award (the “Award”). This Award, founded in 1991 and named after Dr. Reed M. Izatt and Dr. James J. Christensen, two of the founders of IBC, recognizes excellence in macrocyclic and supramolecular chemistry. It is known as one of the most prestigious small awards in chemistry. The Award is presented annually at the International Symposium on Macrocyclic and Supramolecular Chemistry (“ISMSC”). Two of the early recipients of the Award later shared the 2016 Nobel Prize in Chemistry. The precursor of the ISMSC was founded by Dr. Izatt and Dr. Christensen in 1977.

A privately-held Utah corporation, IBC counts among its shareholders a multi-billion dollar international manufacturing company, who has been a major customer and benefactor of IBC for over thirty (30) years. IBC has built its business upon integrity, trust and excellence and values its close association with such top-tier companies.

IBC provides proprietary, green chemistry and green engineering SuperLig® Molecular Recognition Technology products and processes worldwide.  More information can be found at www.ibcmrt.com.

SOURCE IBC Advanced Technologies, Inc.

Related Links

http://www.ibcmrt.com

The post IBC Updates and Corrects the Record on Utah Litigation against Ucore Rare Metals, Inc. appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/ibc-updates-and-corrects-the-record-on-utah-litigation-against-ucore-rare-metals-inc/

[chestnutpost]

Global Brain Computer Interface (BCI) Market Projected to be Worth US$283.04 Mn by 2025 With High Incidence of Brain Disorders

LOS ANGELES and HAMBURG, Germany, June 6, 2019 /PRNewswire/ — QY Research has recently published its new report, titled “Global Brain Computer Interface (BCI) Market Size, Status and Forecast 2019-2025.” It is a specialized and in-depth study of the key market trends and the evolving healthcare industry to understand the growth of the global BCI market. This report aims to provide an overview of the global brain computer interface market with detailed regional analysis, segmentation assessment, and competitive landscape present in the market.

As per the report, the global brain computer interface (BCI) market is estimated to reach US$283.04 mn by 2025 from US$125.21 mn in the year 2018. The market is expected to register a robust CAGR of 12.43% throughout the forecast period of 2019-2025.

Global Brain Computer Interface (BCI) Market: Drivers and Restraints

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson’s disease among the elderly population are expected to boost market growth. The mounting use of BCI technology in the home control systems, military communication, and virtual gaming is expected to enhance the growth opportunities of the global brain computer interface market in the near future. Growing research and development activities by governments to improve brain computer interface technology and expand its end uses are expected to propel the market in the forthcoming years.

However, the high cost of investment in BCI technology will hamper the growth of the market over the forecast period.  

Request Sample Report and Full Report TOC@ https://www.qyresearch.com/sample-form/form/1171787/global-brain-computer-interface-bci-market

Global Brain Computer Interface (BCI) Market: Segment Analysis

The BCI market is segmented into application and product type.  The application segment includes communication, healthcare, gaming and entertainment, and others. Healthcare segment will dominate the global BCI market as the demand for this technology for treating paralytic patients, sleep disorders, and neurological diseases remains high.  The product type is segmented into non-invasive BCI and invasive BCI.

Global Brain Computer Interface (BCI) Market: Regional Analysis

North America is likely to hold the largest market share in the global BCI market due to rapid pace of technological developments in the region. Asia Pacific is also expected to grab a significant market share due to growing investments in research and development activities and increasing government support for developing technologies.

Global Brain Computer Interface (BCI) Market: Leading Players

Artinis Medical Systems BV, NeuroPace Inc, BrainCo, Emotiv Inc, ANT Neuro B.V, InteraXon, Brain Products GmbH, NeuroSky, Inc., Neuroelectrics, Blackrock Microsystems LLC, G.TEC, Compumedics Limited, Advanced Brain Monitoring, and Mindmaze SA are the major players that are operating in the global BCI market.

Global Brain Computer Interface (BCI) Market: Competitive Landscape

Companies are investing in new technologies to experience a digital change for their customer. Both the businesses and the IT leaders are excited to work with cutting-edge technologies such as IoT, virtual reality, and business intelligence to gain a perfect alignment in this competitive market. For instance, one of the top medical technology company, NeuroPace Inc, has introduced its new category, Current Procedural Terminology (CPT) code for electrocorticography from an implanted brain neuro-stimulator. This new code is used to perform with the RNS system of the company for the treatment of the patients suffering from refractory epilepsy.

Global Brain Computer Interface (BCI) Market Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/c3895c55fed6a755f8375b36e9c6c01e,0,1,Global%20Brain%20Computer%20Interface%20(BCI)%20Market%20Size,%20Status%20and%20Forecast%202019-2025

For Any Special Requirement and Custom Request @ https://www.qyresearch.com/customize-request/form/1171787/global-brain-computer-interface-bci-market

Media Contact:

Rahul Singh – Digital Marketing DirectorContact: [phone]Email: [email protected] 

Sales Contact US:

USA Registered Office: QY Research, INC.  17890 Castleton, Suite 218, City of industry, CA – 91748 USA: [phone]Emails – [email protected]

Web – www.qyresearch.com

https://www.qyresearch.com.cn/

https://www.qyrconsulting.com/

Expert News:

https://weeklywall.com/

https://spotherld.com/

https://reviewhealthworld.com/

https://reviewstocksvalue.com/

SOURCE QY Research

The post Global Brain Computer Interface (BCI) Market Projected to be Worth US$283.04 Mn by 2025 With High Incidence of Brain Disorders appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/global-brain-computer-interface-bci-market-projected-to-be-worth-us283-04-mn-by-2025-with-high-incidence-of-brain-disorders/

[chestnutpost]

WesBanco Bank Announces the Appointment of Eric Giesecke as Senior Vice President and Chief Marketing Officer

WHEELING, W.Va., June 6, 2019 /PRNewswire/ — WesBanco, Inc. (Nasdaq: WSBC), a diversified, multi-state bank holding company, announced that its affiliate, WesBanco Bank, has appointed Eric Giesecke as Senior Vice President and Chief Marketing Officer.  In this role, Mr. Giesecke will be responsible for the daily operations and strategic direction of the Marketing Department, as well as establishing and communicating the marketing plan to achieve the bank’s objectives and support its brand.

“We are excited to welcome Eric Giesecke to our management team as our new Chief Marketing Officer,” said Jay Zatta, WesBanco Executive Vice President and Chief Banking Officer.  “Eric is a strong leader, who brings a wealth of banking and marketing experience to WesBanco.  He has been responsible for the development and execution of a multi-channel, integrated marketing strategy across diverse geographies and business lines.  We look forward to the opportunities Eric brings to achieve the successful integration of marketing and business strategies as we continue to grow and strengthen our diversified businesses and enhance our strong market positions across our footprint.”

Mr. Giesecke brings more than 20 years of banking experience to WesBanco, including strategic marketing executive and sales professional roles.  Most recently, he was the Head of Corporate & Institutional Bank Marketing for PNC Bank where he led a team of 20 professionals.  Eric brings significant marketing experience in direct, digital, and mass media strategies; brand positioning and differentiated messaging; localized marketing; and the integration of marketing and sales.

Todd F. Clossin, WesBanco President and Chief Executive Officer, stated, “I am very pleased that someone with Eric’s background and expertise has joined the WesBanco family to lead our marketing team.  He is a proven leader who has both the experience and insight to bring our marketing strategy to the next level.”

About WesBanco, Inc.Founded in 1870, WesBanco, Inc. (www.wesbanco.com) is a multi-state, bank holding company with total assets of approximately $12.6 billion (as of March 31, 2019).  WesBanco is a diversified and well-balanced financial services institution, with a community bank at its core, built upon a strong legacy of credit and risk management.  WesBanco has meaningful market share across its key geographies maintained by its commitment to dedicated customer service and solid fee-based businesses. It also provides wealth management services through a century-old trust and wealth management business, with approximately $4.5 billion of assets under management (as of March 31, 2019), and serves as registered investment advisor to a proprietary mutual fund family, the WesMark Funds.  WesBanco’s banking subsidiary, WesBanco Bank, Inc., operates 203 financial centers in the states of Indiana, Kentucky, Ohio, Pennsylvania, and West Virginia.  In addition, WesBanco operates an insurance agency, WesBanco Insurance Services, Inc., and a full service broker/dealer, WesBanco Securities, Inc.

SOURCE WesBanco, Inc.

Related Links

http://www.wesbanco.com

The post WesBanco Bank Announces the Appointment of Eric Giesecke as Senior Vice President and Chief Marketing Officer appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/wesbanco-bank-announces-the-appointment-of-eric-giesecke-as-senior-vice-president-and-chief-marketing-officer/

[chestnutpost]

DRB Capital Settles Lawsuit, Continues to Fight Illegal and Unethical Practices

DELRAY BEACH, Fla., June 6, 2019 /PRNewswire/ — DRB Capital, LLC (“DRB Capital”) is pleased to announce that it has settled one of several lawsuits the company has filed for unfair and deceptive trade practices related to its structured settlement factoring business.  By settling this complaint filed with the Circuit Courts of Broward County, DRB continues its aggressive efforts to uncover and stop illegal conduct in the structured settlement factoring market.

“DRB will continue and expand its policy of filing suit against any party that engages in unfair, deceptive or tortious acts that damage our business,” said DRB’s General Counsel, Ina Berlingeri.

On August 8th, 2018 DRB established a private fund to pay awards totaling up to $100,000 to those who come forward with information proving violations of various laws in connection with the business of purchasing structured settlement payment rights. Violations include the tax code, violations of state structured settlement protection acts, improper forum shopping, violations of state and federal deceptive and unfair trade practices act, and federal excise tax evasion. 

Since the bounty program’s launch, DRB Capital has awarded multiple payouts and received numerous tips and credible information about these unfair, deceptive and abusive activities. 

To be eligible for a bounty, your information must be accurate and show these violations to a satisfactory legal standard. You may be required to give testimony to law enforcement and in legal proceedings.  Please visit www.StopStructuredFraud.com for more details on how to participate in this program and for the full list of eligibility requirements.

About DRB Capital, LLC:  DRB Capital, LLC (“DRB” or the “Company”) is a wholly owned subsidiary of DRB Financial Solutions, LLC.  DRB is one of the most trusted annuity buyers in America and is a national specialty servicing company. The Company’s primary focus is to provide asset management and high touch servicing for investors in specialty finance space. DRB services various asset classes on behalf of commercial banks, hedge funds, private equity firms as well as servicing private placement deals. DRB was founded on the principle that a combination of technology, deep industry experience, collection accuracy and a contrarian view of servicing can make a significant difference in the quality of services provided to institutional lenders and investors. Servicing solutions include asset and esoteric asset due diligence, servicing, data analytics, and reporting, as well as capital markets expertise.  DRB is currently servicing in excess of 50,000 units.  Visit: www.drbcapital.com.

Contact:  Mark Mruz, 561-982-3486

SOURCE DRB Capital, LLC

Related Links

http://www.drbcapital.com

The post DRB Capital Settles Lawsuit, Continues to Fight Illegal and Unethical Practices appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/drb-capital-settles-lawsuit-continues-to-fight-illegal-and-unethical-practices/

[chestnutpost]

Genstar Capital Announces Agreement to Acquire Advarra from Linden Capital Partners

SAN FRANCISCO, June 6, 2019 /PRNewswire/ — Genstar Capital (“Genstar”), a leading private equity firm focused on investments in targeted segments of the healthcare, software, industrial technology, and financial services industries, announced today that it has recently signed a definitive agreement to acquire Advarra (“Advarra” or the “Company”), a leading provider of compliance solutions that are critical to the drug development process, from Linden Capital Partners (“Linden”), which intends to reinvest in the Company via a minority investment upon completion of the transaction.

Advarra is a leading provider of institutional review board (IRB), institutional biosafety committee (IBC) and research quality and compliance services, which are mandated by regulatory agencies for all trial protocols, patient forms, site initiations and trial modifications. The Company serves leading pharmaceutical, biotechnology, medical device and contract research organizations (CROs), as well as academic medical centers, hospital systems, investigative site networks, and therapeutic research consortia, and has relationships with over 3,200 institutional sites. Advarra is headquartered in Columbia, MD and was formed through the merger of Chesapeake IRB and Schulman IRB in 2017; in March 2019, the Company completed its acquisition of Quorum Review.

David Golde, Managing Director of Genstar, said, “Genstar has a long track record of building industry-leading businesses in the pharmaceutical services sector through our investments in CRF Bracket, ERT, and PRA Health Sciences, among others. We were extremely impressed with the market leading platform that Pat Donnelly and his team have built in the regulatory compliance segment of clinical trials. We are excited for Advarra to continue leveraging its leading reputation in the IRB and regulatory compliance industry, while expanding, both organically and through strategic acquisitions, into other ancillary services to better serve its customers. Genstar looks forward to collaborating with Advarra’s management team to further its mission with all of the constituencies that depend upon safe and efficient progress of pharmaceutical research.”

Pat Donnelly, Chief Executive Officer of Advarra, said, “IRBs are required and critical to the drug development process and the increasing complexity of clinical trials and need to adhere to evolving and strict FDA guidelines will continue to drive the importance of our services. Advarra is devoted to enhancing the safety of clinical trial subjects around the world and to improving the efficiency of clinical trial execution for all stakeholders including sponsors, academic institutions, hospital systems, and CROs. This new partnership with Genstar augments our resources to further the important mission of our Company and to continue to unlock value for our customers. On behalf of the management team, we are grateful for Linden’s strong stewardship over the last several years.”

Tony Davis, President and Managing Partner at Linden, said, “We are proud to have played a role scaling Advarra into a truly differentiated platform as the industry-leading IRB, which is a result of our targeted value creation initiatives over the last three and a half years, most notably significantly investing in infrastructure and strategic acquisitions. The Company is very well positioned to continue on its growth trajectory, building on a long history of outperformance, superior human subject protection and leading therapeutic area specialization. We are excited about our intention to invest alongside Genstar and continue to support Advarra through its next phase of growth.”

Jefferies is serving as lead financial advisor and Houlihan Lokey is serving as co-financial advisor to Linden and Advarra. Kirkland & Ellis LLP is serving as legal counsel to Linden and Advarra in connection with this transaction. Ropes & Gray LLP is serving as legal counsel to Genstar.

About AdvarraAdvarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC), and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers, and investigators. Its robust

regulatory expertise and innovative technology ensure the highest standards of research review are met, while putting participants first and meeting complex human research protection oversight requirements. Advarra supports all phases of research across multiple therapeutic areas. Visit www.advarra.com.

About Genstar CapitalGenstar Capital is a leading private equity firm that has been actively investing in high quality companies for over 30 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $17 billion of assets under management and targets investments focused on targeted segments of the healthcare, software, industrial technology, and financial services industries. For more information on Genstar, please visit: www.gencap.com.

About Linden Capital PartnersLinden Capital Partners is a Chicago-based private equity firm focused exclusively on investing in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms across the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.

Contact: Chris Tofalli                                                                                     Chris Tofalli Public Relations                                                                         914-834-4334

SOURCE Genstar Capital

Related Links

http://www.gencap.com

The post Genstar Capital Announces Agreement to Acquire Advarra from Linden Capital Partners appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/genstar-capital-announces-agreement-to-acquire-advarra-from-linden-capital-partners/

[chestnutpost]

Adorama Appoints Michael Amkreutz to Chief Executive Officer

NEW YORK, June 6, 2019 /PRNewswire/ — Adorama, one of the world’s largest photography, video, audio and computer retailers, is proud to appoint Michael Amkreutz to Chief Executive Officer, effective June 3, 2019.

Prior to joining Adorama, Amkreutz served as Chief Merchandising Officer at Guitar Center.

Eugene Mendlowits, Chairman and Owner of Adorama says: “Michael has significant business experience in growing and improving consumer electronics, retail, and e-commerce-based businesses with an emphasis on marketing, merchandising, and customer relationships. He is a people- and customer-centered individual with a strong history of leading highly engaged teams, and has a proven record of taking customer-centric companies to the next level. This makes him ideally suited to Adorama’s customer intimacy strategy.”

Amkreutz adds: “Adorama is the preeminent source for all creators, with a decades-long legacy of serving professionals. I am proud to join the company and bring my expertise in merchandising, marketing, and e-commerce to elevate the brand to new heights.”

ADORAMA: More Than a Camera Store Adorama is more than a camera store – it’s one of the world’s largest photography, video, audio and computer retailers. Serving customers for more than 40 years, Adorama has grown from its flagship NYC store to include the leading online destination for imaging and consumer electronics. Adorama’s product offerings encompass home entertainment, mobile computing, professional video and audio, the award-winning Adorama Learning Center, and AdoramaTV. Adorama is listed as one of the top five electronics retailers by Consumer Reports, “Best of the Web” by Forbes.com, and Internet Retailers Top 100.

Visit ADORAMA at www.adorama.com.

Press Contact Irwin Rommel Suba (e) [email protected] (p) 646.321.3263

SOURCE Adorama

Related Links

https://www.adorama.com

The post Adorama Appoints Michael Amkreutz to Chief Executive Officer appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/adorama-appoints-michael-amkreutz-to-chief-executive-officer/

[chestnutpost]

RateGain Partners With OYO Hotels & Homes

LONDON, June 6, 2019 /PRNewswire/ — RateGain today announced a strategic global partnership with OYO Hotels & Homes, the world’s 6th largest chain of hotels, homes, and living spaces to extend its distribution platform RezGain to OYO. RateGain will enable OYO to leverage RezGain to make the OYO inventory available on 700+ OTA’s across more than 80 countries.

Through this strategic partnership, RateGain will provide distribution to OYO to reach global and regional demand channels to spur its expansion. It will also support OYO’s efforts to standardize across its vast portfolio and increase its reach worldwide by offering access to new channels, and to drive innovation in distribution by testing next generation distribution technologies that will help hotel chains like OYO in optimizing their distribution while dramatically shortening their time-to-market.

With connections to over 287 global demand partners, 600 long-tail OTAs, TMCs, all major GDS systems and wholesalers, RateGain provides hospitality industry with the world’s largest distribution ecosystem.

Commenting on the development Apurva Chamaria, Chief Revenue Officer, RateGain, said, “We are excited to work with the dynamic OYO Hotels & Homes teams and support their mission to increase occupancy and revenue by bringing quality living spaces to a billion plus people with our distribution platform. Hence, enabling their efforts to expand their network to new channels and marketplaces across the globe. We are thrilled about partnering with another hospitality innovator to market test the next generation of distribution solutions, which will leverage Artificial Intelligence and Machine Learning to redefine what distribution looks like.”

Talking about the partnership, Abhinav Sinha, Global Chief Operating Officer, OYO Hotels & Homes, said, “We are excited to have RateGain as our global distribution technology partner and to support us in our endeavors of reaching out to travelers across the world. We selected RateGain’s distribution platform after evaluating multiple solutions because of their cutting-edge features offered and the comprehensiveness of the distribution capability. At OYO, our mission is to create a perfect space in every place by ensuring the best possible experience for our guests, and having RateGain as a strategic distribution partner supports this vision.”

With 1,26,000+ hospitality clients and enabling 5m+ transactions per year, RateGain is a leader in hospitality distribution landscape. The distribution platform consisting of RezGain channel management and DHISCO, enabling hospitality distribution across all continents from independent hotels to all major hotels chains.

About RateGain:

RateGain is the #1 provider of SaaS products helping more than 12,000+ customers including every Fortune 500 travel and hospitality company make more revenue every day. For more information, visit www.rategain.com.

About OYO Hotels and Homes:

OYO is the world’s 6th largest hotel chain and the world’s fastest growing chain of hotels, homes & spaces! With @Leisure Group joining the chain, OYO today has more than 45,000-holiday homes, footprints in more than 800 cities across 24 countries. For more information, visit https://www.oyorooms.com/.

Media Contact:

Aditi Bhandari Senior Manager [email protected][phone]

SOURCE RateGain

The post RateGain Partners With OYO Hotels & Homes appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/rategain-partners-with-oyo-hotels-amp-homes/

[chestnutpost]

The Hilb Group, LLC Adds Pfister Insurance, Inc.

RICHMOND, Va., June 6, 2019 /PRNewswire/ — The Hilb Group, LLC (“THG”) announced today the acquisition of Delaware-based Pfister Insurance, Inc (“Pfister”). The transaction became effective June 1, 2019.

Located in Dover, Pfister is a full-service property & casualty agency primarily providing business, auto & home insurance to clients in the Mid-Atlantic region. Pfister’s agency leaders, Mel Warren, Jim Watkins, and Scott Foltz, will continue to lead the agency’s associates out of their current office location.

“Pfister greatly values our clients and we will always do what it takes to deliver the best quality coverage and service possible,” said Warren. “Joining THG will allow us to provide our clients additional resources and support of a national brokerage, while they will continue to work with a team they know and trust.”

“The Pfister team has done an outstanding job building a firm whose primary focus will remain the clients’ success,” said Ricky Spiro, THG CEO. ” Pfister’s reputation and dedicated team makes a great addition to continue our growth in the Mid-Atlantic region.”

About the Hilb Group: The Hilb Group is a leading middle market insurance agency headquartered in Richmond, Virginia and is a portfolio company of Boston-based private equity firm, Abry Partners. The Hilb Group seeks to grow through targeted acquisitions in the middle market insurance brokerage space. The company now has 81 offices in 19 states. Please visit our website at: http://hilbgroup.com.

Media Contact:Margaret Clary [email protected]

M&A Contact:Ryan Havermann [email protected]

SOURCE The Hilb Group, LLC

Related Links

http://www.hilbgroup.com

The post The Hilb Group, LLC Adds Pfister Insurance, Inc. appeared first on The Chestnut Post.

from The Chestnut Post https://www.thechestnutpost.com/news/the-hilb-group-llc-adds-pfister-insurance-inc/